Sign in
4

Changes in Ownership

Traws Pharma, Inc. Filed Acc 0001415889-23-002167

CFO AND COO gave up 1,785 shares (to pay taxes)

  • CFO AND COO acquired 6,900 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Guerin Mark Patrick CFO AND COO 2023-02-07 Option exercise +6,900 19,976 D
Guerin Mark Patrick CFO AND COO 2023-02-07 Shares withheld for taxes −1,785 $1.36 $2,428 18,191 D
Derivatives
Guerin Mark Patrick CFO AND COO 2023-02-07 Option exercise · Restricted Stock Units −6,900 13,800 D
Loading xslF345X03/form4-02082023_100254.xml…